Abstract:AbstractBackgroundTo explore the value of the modified qualitative scoring of MMSE pentagon test (mQSPT) in the differential diagnosis of Lewy body dementia (DLB) and Alzheimer’s disease (AD).MethodStudy the patients who met the inclusion criteria in the Department of Neurology, Xuanwu Hospital, Capital Medical University from January 2018 to August 2021. The baseline data of gender, age and education, Mini‐Mental State Examination (MMSE), Montreal Cognitive Assessment Scale (MoCA) and Clinical Dementia Assessment Scale (CDR) scores of 61 DLB patients and 71 AD patients were analyzed retrospectively. At the same time, the scores of sub items in the scale that can reflect visualspatial impairment were recorded,: i.e. connection test, cube copy, clock drawing test in MoCA, and pentagon copy test in MMSE. The images in MMSE pentagon copy test of these patients were further scored according to QSPT and mQSPT, and compared between the two groups. Multivariate stepwise logistic regression was used to analyze the differential efficacy of QSPT, mQSPT combined with other clinical psychological evaluation between DLB and AD.ResultThere were significant differences between DLB and AD patients in connection test, cube copy, clock drawing test, pentagon copy test, QSPT, mQSPT and gender, but there were no significant differences in MMSE, MoCA, age and education. The sensitivity of QSPT in differentiating DLB and AD was 71.8%, the specificity was 67.2%, the area under ROC curve was 0.682 (95%CI: 0.584‐0.772), and the cut‐off value was 9.5. The sensitivity of mQSPT in differentiating DLB and AD was 68.9%, the specificity was 84.5%, the area under ROC curve was 0.78 (95%CI: 0.696‐0.862), and the cut‐off value was 8.5. Multivariate stepwise logistic regression showed that while QSPT failed to establish any suitable modeling, mQSPT and cube copy were related to the distinction between the two diseases. Moreover, the efficacy of these two indexes to distinguish AD and DLB: the sensitivity was 70.5%, and the specificity was 84.1% and the area under the ROC curve was 0.817(95%CI: 0.743‐0.891).ConclusionThe mQSPT can be used for the screening tool in differential diagnosis between AD and DLB patients.

The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia

Comparing the neuropsychological profiles of mild dementia with Lewy bodies and mild Alzheimer's disease.

Gesture imitation performance in community‐dwelling older people: assessment of a gesture imitation task in the screening and diagnosis of mild cognitive impairment and dementia

Extended Application of Digital Clock Drawing Test in the Evaluation of Alzheimer's Disease Based on Artificial Intelligence and the Neural Basis

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

Examining the Diagnostic Accuracy of a Novel Performance-Based Test for Alzheimer's Disease Screening

Discrepancy of the Two Clock Drawing Tests in Evaluating Alzheimer's Disease

Validity of Long-delayed Recall Test on the Diagnosis of Alzheimer Disease

Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers

A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease

Application of the Modified Qualitative Scoring of MMSE Pentagon Test in the Differential Diagnosis of Lewy Body Dementia and Alzheimer’s Disease

Extrapyramidal Signs By Dementia Severity In Alzheimer Disease And Dementia With Lewy Bodies

Fanction of Three-point Scoring System for the Clock Drawing Test in Differentiating Between Alzheimer's Disease and Vascular Dementia in China

Detecting Dementia: Novel Neuropsychological Markers of Preclinical Alzheimer&rsquo;s Disease

Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study

P3‐110: the Utility of Combining Ad8 and Clock Drawing Test in Dementia Screening

Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT

Significance of Clock Drawing Test in Diagnosis of Alzheimer's Disease

A Practical Screening Combination for the Discrimination of Alzheimer's Type Memory Impairment Continuum: The 5-word Test and Magnetic Resonance Imaging-visual Rating Scale

Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies

Biomarker Use for Dementia With Lewy Body Diagnosis: Survey of US Experts